Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for AMITRIPTYLINE HYDROCHLORIDE

Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-AMITRIPTYLINE	50MG	TABLET	Resolved	2021-06-03	2022-01-07	140405
TEVA-AMITRIPTYLINE	50MG	TABLET	Resolved	2021-05-27	2021-08-06	140033
TEVA-AMITRIPTYLINE	50MG	TABLET	Resolved	2017-03-14	2017-05-23	2437

Previous
1
…
6
7
8

Showing 71 to 73 of 73

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
APO-AMITRIPTYLINE	25MG	TABLET	Discontinued	2019-01-04	2019-02-13	71351
APO-AMITRIPTYLINE	10MG	TABLET	Discontinued	2019-01-04	2019-01-04	71348
ELAVIL	25MG	TABLET	To be discontinued	2025-01-16	2025-01-16	247833
ELAVIL	25MG	TABLET	To be discontinued	2025-01-16	2025-01-16	247830
ELAVIL	10MG	TABLET	To be discontinued	2025-01-16	2025-01-16	247827
ELAVIL	10MG	TABLET	To be discontinued	2025-01-16	2025-01-16	247824
ELAVIL	50MG	TABLET	To be discontinued	2025-01-16	2025-01-16	247839
ELAVIL	75MG	TABLET	To be discontinued	2025-01-16	2025-01-16	247842
ELAVIL	50MG	TABLET	To be discontinued	2025-01-16	2025-01-16	247836
TEVA-AMITRIPTYLINE	50MG	TABLET	Discontinued	2022-01-07	2022-01-07	152378

Showing 11 to 20 of 25